ROSS HANSEN: Open Payments
NPI 1679702815 · WAKEFIELD, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$363 in 22 payments from 8 companies in 2025. Trend: 2023 $490 · 2024 $10,366 · 2025 $363
Food & beverage: $363
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $145 |
| Astellas Pharma US Inc | 4 | $72 |
| PFIZER INC. | 2 | $37 |
| Amgen Inc. | 2 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| GENZYME CORPORATION | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
Products named: Ozempic, Veozah, NURTEC ODT, EVENITY, CAPLYTA, Kerendia, DUPIXENT, Dexcom G6 Transmitter.
Industry payments across NE — which companies pay providers there.
